Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CoreWeave
CRWV
5
Palantir
PLTR
HK Stock MarketDetailed Quotes
01787 SD GOLD
- 18.480
- -0.020-0.11%
Not Open Apr 1 16:08 CST
82.67BMarket Cap30.70P/E (TTM)
18.860High18.200Low19.10MVolume18.500Open18.500Pre Close353.41MTurnover2.22%Turnover Ratio30.70P/E (Static)4.47BShares19.63952wk High3.09P/B15.87BFloat Cap12.44052wk Low0.24Dividend TTM858.99MShs Float26.862Historical High0.154Dividend LFY3.57%Amplitude6.059Historical Low18.502Avg Price250Lot Size1.30%Div YieldTTM0.83%Div Yield LFY
SD GOLD Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 39.21%82.52B | 62.15%67.01B | 66.90%45.77B | 44.73%18.96B | 17.83%59.28B | 3.75%41.32B | -8.05%27.42B | -2.84%13.1B | 48.25%50.31B | 124.90%39.83B |
| Operating income | 39.21%82.52B | 62.15%67.01B | 66.90%45.77B | 44.73%18.96B | 17.83%59.28B | 3.75%41.32B | -8.05%27.42B | -2.84%13.1B | 48.25%50.31B | 124.90%39.83B |
| Cost of sales | -38.81%-70.3B | ---- | -66.69%-40.11B | ---- | -14.75%-50.65B | ---- | 10.19%-24.06B | ---- | -39.87%-44.14B | ---- |
| Operating expenses | -38.81%-70.3B | -62.68%-57.04B | -66.69%-40.11B | -44.62%-16.2B | -14.75%-50.65B | -2.18%-35.06B | 10.19%-24.06B | 4.31%-11.2B | -39.87%-44.14B | -111.80%-34.31B |
| Gross profit | 41.56%12.21B | 59.20%9.97B | 68.47%5.67B | 45.42%2.76B | 39.89%8.63B | 13.54%6.26B | 10.88%3.36B | 6.84%1.9B | 159.67%6.17B | 265.57%5.52B |
| Selling expenses | -25.41%-184.58M | -34.53%-119.6M | -40.65%-83.11M | -60.94%-38.97M | 16.58%-147.18M | 34.46%-88.9M | 41.38%-59.09M | 58.03%-24.21M | 51.15%-176.42M | 40.34%-135.65M |
| Administrative expenses | -12.37%-2.94B | -8.08%-1.94B | -26.98%-1.42B | -0.90%-600.06M | -6.05%-2.61B | 19.57%-1.79B | 5.76%-1.11B | 18.89%-594.7M | -2.33%-2.47B | -6.06%-2.23B |
| Research and development expenses | -58.13%-770.41M | -51.56%-484.14M | -56.54%-258.16M | -40.49%-94.53M | -21.93%-487.2M | -11.26%-319.44M | 4.93%-164.92M | -16.52%-67.28M | -15.61%-399.57M | -40.73%-287.12M |
| Profit from asset sales | ---- | -141.86%-179.73K | ---- | -92.36%84.29K | ---- | 168.05%429.37K | ---- | --1.1M | ---- | -9.66%-630.91K |
| Revaluation surplus | ---- | -1,491.88%-397.02M | ---- | 111.85%9.32M | ---- | 109.71%28.52M | ---- | -222.26%-78.66M | ---- | -167.44%-293.86M |
| -Changes in the fair value of other assets | ---- | -1,491.88%-397.02M | ---- | 111.85%9.32M | ---- | 109.71%28.52M | ---- | -222.26%-78.66M | ---- | -167.44%-293.86M |
| Impairment and provision | ---- | 79.48%-8.43M | ---- | 27.26%-8.95M | ---- | -1,971.98%-41.09M | ---- | -1,614.37%-12.31M | ---- | -58.71%2.2M |
| -Other impairment is provision | ---- | 79.48%-8.43M | ---- | 27.26%-8.95M | ---- | -1,971.98%-41.09M | ---- | -1,614.37%-12.31M | ---- | -58.71%2.2M |
| Special items of operating profit | -77.51%-855.99M | -325.47%-132.13M | -410.95%-324.62M | -114.15%-11.72M | -64.75%-482.22M | -43.47%58.6M | 53.92%-63.53M | 441.92%82.83M | -120.32%-292.7M | -70.70%103.67M |
| Operating profit | 52.45%7.46B | 75.90%5.94B | 82.79%3.58B | 74.69%1.72B | 72.83%4.9B | 63.01%3.38B | 111.28%1.96B | 27.92%986.73M | 8,502.74%2.83B | 462.54%2.07B |
| Financing income | 30.95%190.02M | ---- | 86.03%94.98M | ---- | 70.42%145.11M | ---- | --51.06M | ---- | --85.15M | ---- |
| Financing cost | -32.28%-2.07B | -37.98%-1.54B | -31.16%-921.17M | -4.32%-334.19M | -49.22%-1.57B | -44.77%-1.12B | ---702.32M | -55.96%-320.34M | ---1.05B | -42.15%-771.75M |
| Share of profits of associates | 119.76%33.49M | ---- | -18.01%14.78M | ---- | -56.80%15.24M | ---- | -7.56%18.02M | ---- | 61.65%35.27M | ---- |
| Adjustment items of earning before tax | ---- | 20.47%-30.75M | ---- | -537.24%-17.83M | ---- | 52.21%-38.67M | ---- | 91.92%-2.8M | ---- | -934.62%-80.92M |
| Earning before tax | 60.92%5.61B | 96.65%4.37B | 108.86%2.77B | 106.71%1.37B | 83.37%3.49B | 82.21%2.22B | 40.11%1.33B | 24.88%663.59M | 16,093.94%1.9B | 210.35%1.22B |
| Tax | -84.30%-1.23B | -88.20%-1.06B | -84.36%-641.32M | -98.18%-316.11M | -21.23%-664.97M | -33.54%-562.64M | 6.12%-347.86M | 9.47%-159.51M | -152.06%-548.53M | -46.59%-421.33M |
| After-tax profit from continuing operations | 55.41%4.39B | 99.52%3.31B | 117.56%2.13B | 109.41%1.06B | 108.54%2.82B | 107.92%1.66B | 69.79%979.83M | 41.92%504.09M | 689.85%1.35B | 157.30%797.61M |
| Earning after tax | 55.41%4.39B | 99.52%3.31B | 117.56%2.13B | 109.41%1.06B | 108.54%2.82B | 107.92%1.66B | 69.79%979.83M | 41.92%504.09M | 689.85%1.35B | 157.30%797.61M |
| Minority profit | 167.86%1.49B | 296.88%1.24B | 518.52%774.71M | 445.39%355.72M | 246.63%555.86M | 199.31%313.18M | 173.47%125.25M | 62.11%65.22M | 2,052.53%160.36M | 290.70%104.64M |
| Profit attributable to shareholders | 27.84%2.9B | 53.57%2.07B | 58.79%1.36B | 59.48%699.89M | 89.99%2.27B | 94.12%1.35B | 60.85%854.58M | 39.34%438.87M | 639.28%1.19B | 151.82%692.98M |
| Basic earnings per share | 40.00%0.56 | 69.57%0.39 | 85.71%0.26 | 85.71%0.13 | 110.53%0.4 | 130.00%0.23 | 55.56%0.14 | 40.00%0.07 | 290.00%0.19 | 133.33%0.1 |
| Diluted earnings per share | 40.00%0.56 | 69.57%0.39 | 85.71%0.26 | 85.71%0.13 | 110.53%0.4 | 130.00%0.23 | 55.56%0.14 | 40.00%0.07 | 290.00%0.19 | 133.33%0.1 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.